M. Fasano

2.3k total citations
55 papers, 1.1k citations indexed

About

M. Fasano is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, M. Fasano has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hepatology, 31 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in M. Fasano's work include Hepatitis C virus research (31 papers), Hepatitis B Virus Studies (26 papers) and Liver Disease Diagnosis and Treatment (23 papers). M. Fasano is often cited by papers focused on Hepatitis C virus research (31 papers), Hepatitis B Virus Studies (26 papers) and Liver Disease Diagnosis and Treatment (23 papers). M. Fasano collaborates with scholars based in Italy, United States and France. M. Fasano's co-authors include Teresa Santantonio, S. Rendine, A. Guastadisegni, Giuseppe Pastore, M Carbone, M Carrozzo, S Gandolfo, S. Roggero, C Casalino and Ruggiero Francavilla and has published in prestigious journals such as Hepatology, Gut and Journal of Hepatology.

In The Last Decade

M. Fasano

53 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Fasano Italy 18 708 698 137 102 93 55 1.1k
Fu‐Hsiung Su Taiwan 18 431 0.6× 528 0.8× 55 0.4× 53 0.5× 11 0.1× 39 833
E. Kaklamani Greece 11 272 0.4× 338 0.5× 167 1.2× 40 0.4× 13 0.1× 25 724
Parag Mahale United States 19 554 0.8× 585 0.8× 56 0.4× 151 1.5× 6 0.1× 56 1.1k
Antje Knöll Germany 21 323 0.5× 454 0.7× 61 0.4× 104 1.0× 7 0.1× 43 1.1k
J F Colombel United States 18 97 0.1× 621 0.9× 128 0.9× 22 0.2× 20 0.2× 69 1.0k
Hans Verbaan Sweden 19 1.0k 1.5× 1.6k 2.3× 164 1.2× 58 0.6× 5 0.1× 44 2.0k
Weibin Bao United States 14 454 0.6× 476 0.7× 232 1.7× 22 0.2× 5 0.1× 27 1.3k
J. H. DOBLOUG Norway 17 150 0.2× 197 0.3× 521 3.8× 45 0.4× 24 0.3× 28 1.1k
W. P. Schaasberg Netherlands 17 925 1.3× 891 1.3× 184 1.3× 59 0.6× 3 0.0× 23 1.6k
Tony Andréani France 11 962 1.4× 977 1.4× 92 0.7× 23 0.2× 4 0.0× 20 1.2k

Countries citing papers authored by M. Fasano

Since Specialization
Citations

This map shows the geographic impact of M. Fasano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fasano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fasano more than expected).

Fields of papers citing papers by M. Fasano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Fasano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fasano. The network helps show where M. Fasano may publish in the future.

Co-authorship network of co-authors of M. Fasano

This figure shows the co-authorship network connecting the top 25 collaborators of M. Fasano. A scholar is included among the top collaborators of M. Fasano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Fasano. M. Fasano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inchingolo, Angelo Michele, Vitalba Ruggieri, M. Fasano, et al.. (2023). Inflammation as Prognostic Hallmark of Clinical Outcome in Patients with SARS-CoV-2 Infection. Life. 13(2). 322–322. 4 indexed citations
2.
3.
Fasano, M., Michele Stanislaw Milella, Sergio Carbonara, et al.. (2023). Apulian infectious diseases network: survey on the prevalence of delta infection among chronic HBV carriers in Apulia. Frontiers in Public Health. 11. 1247454–1247454.
4.
Fasano, M., et al.. (2022). Management of Chronic Hepatitis B in HIV-Coinfected Patients. Viruses. 14(9). 2022–2022. 6 indexed citations
5.
Niro, Grazia Anna, Antonina Smedile, Rosanna Fontana, et al.. (2016). HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response. Alimentary Pharmacology & Therapeutics. 44(6). 620–628. 40 indexed citations
6.
Bruno, Giuseppe, M. Fasano, Annalisa Saracino, et al.. (2015). Real life experience in treatment of HIV-1/HCV-coinfected patients with pegylated interferon alpha and ribavirin: predictors of SVR.. PubMed. 38(1). 21–7. 1 indexed citations
7.
Andriulli, Angelo, Filomena Morisco, A Ippolito, et al.. (2014). HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome. Hepatology International. 9(1). 52–57. 6 indexed citations
8.
Santantonio, Teresa, M. Fasano, Evangelista Sagnelli, et al.. (2014). Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin. Hepatology. 59(6). 2101–2109. 28 indexed citations
9.
Sagnelli, Evangelista, Teresa Santantonio, Nicola Coppola, et al.. (2014). Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment. Infection. 42(4). 601–610. 20 indexed citations
10.
Lampertico, Pietro, Mauro Viganò, G.G. Di Costanzo, et al.. (2012). Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B. Gut. 62(2). 290–298. 83 indexed citations
11.
Fasano, M., Pietro Lampertico, Alfredo Marzano, et al.. (2012). HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years. Journal of Hepatology. 56(6). 1254–1258. 23 indexed citations
12.
Lampertico, Pietro, M Viganò, Alfonso Galeota Lanza, et al.. (2011). 730 PEGBELIVER STUDY: HBSAG DECLINE AT WEEK 24 OF EXTENDED PEGINTERFERON ALFA-2A (PEG-IFNα-2A) THERAPY IS SIGNIFICANTLY ASSOCIATED WITH POST-TREATMENT RESPONSE IN HBEAG-NEGATIVE GENOTYPE D PATIENTS. Journal of Hepatology. 54. S293–S293. 5 indexed citations
13.
Scagnolari, Carolina, Michele Stanislaw Milella, Giovanni Battista Gaeta, et al.. (2011). Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α. Clinical Microbiology and Infection. 18(10). 1033–1039. 12 indexed citations
14.
Fasano, M., et al.. (2008). Therapy of Acute Hepatitis C: A Review of Literature. Current Pharmaceutical Design. 14(17). 1686–1689. 8 indexed citations
15.
Santantonio, Teresa, M. Fasano, A. Guastadisegni, et al.. (2004). Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. Journal of Hepatology. 42(3). 329–333. 110 indexed citations
16.
Bolognesi, Elisabetta, et al.. (2001). MICA and MICB microsatellite alleles in HLA extended haplotypes. European Journal of Immunogenetics. 28(5). 523–530. 24 indexed citations
17.
Carrozzo, M, Paola Francia di Celle, S Gandolfo, et al.. (2001). Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. British Journal of Dermatology. 144(4). 803–808. 101 indexed citations
18.
Carrozzo, M, M. Fasano, Roberto Broccoletti, et al.. (2001). HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity.. British Journal of Dermatology. 145(5). 805–808. 31 indexed citations
19.
Amoroso, Antonio, Serena Vatta, Sérgio Crovella, et al.. (1998). Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schoenlein patients. Nephrology Dialysis Transplantation. 13(12). 3184–3188. 29 indexed citations
20.
Amoroso, Antonio, et al.. (1991). HLA class II gene frequencies in Italy.. PubMed. 5(1-2). 75–86. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fu‐Hsiung Su Breakdown of academic impact, for papers by E. Kaklamani Breakdown of academic impact, for papers by Parag Mahale Breakdown of academic impact, for papers by Antje Knöll Breakdown of academic impact, for papers by J F Colombel Breakdown of academic impact, for papers by Hans Verbaan Breakdown of academic impact, for papers by Weibin Bao Breakdown of academic impact, for papers by J. H. DOBLOUG Breakdown of academic impact, for papers by W. P. Schaasberg Breakdown of academic impact, for papers by Tony Andréani
Rankless by CCL
2026